Insulin and hyperandrogenism in women with polycystic ovary syndrome

CG Baptiste, MC Battista, A Trottier… - The Journal of steroid …, 2010 - Elsevier
Polycystic ovary syndrome (PCOS) is a very common endocrine disorder characterized by
chronic anovulation, clinical and/or biochemical hyperandrogenism, and/or polycystic …

New perspectives in polycystic ovary syndrome

E Diamanti-Kandarakis, A Dunaif - Trends in Endocrinology & Metabolism, 1996 - cell.com
Polycystic ovary syndrome (PCOS) is, perhaps, the most common endocrinopathy affecting
premenopausal women. Of such women, 5%–10% have the classic endocrine syndrome of …

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

MO Goodarzi, DA Dumesic, G Chazenbalk… - Nature reviews …, 2011 - nature.com
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of
reproductive age, with a prevalence of up to 10%. Various diagnostic criteria have been …

Androgens and insulin–two key players in polycystic ovary syndrome

AN Schüring, N Schulte, B Sonntag… - Gynäkologisch …, 2008 - karger.com
Androgens and insulin are endocrine key players in the pathophysiology of polycystic ovary
syndrome (PCOS), a heterogenic condition of unexplained etiology and a suspected genetic …

Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling

R Azziz - The Journal of Clinical Endocrinology & Metabolism, 2002 - academic.oup.com
The polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders,
affecting 4–6% of unselected women of reproductive age. More recently, it has been …

[HTML][HTML] Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance

TM Barber, GK Dimitriadis, A Andreou, S Franks - Clinical Medicine, 2016 - Elsevier
Polycystic ovary syndrome (PCOS) is a common condition that typically develops in
reproductive-age women. The cardinal clinical and biochemical characteristics of PCOS …

Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity

X Zeng, Y Xie, Y Liu, S Long, Z Mo - Clinica chimica acta, 2020 - Elsevier
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine disease
characterized by clinical or laboratorial hyperandrogenism, oligo-anovulation and metabolic …

Polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?

JP Baillargeon, JE Nestler - The Journal of Clinical …, 2006 - academic.oup.com
Polycystic ovary syndrome (PCOS) affects 6–10% of women of child-bearing age (1). It is
defined by hyperandrogenism, chronic anovulation, and/or polycystic ovaries (two of three …

Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications

JE Nestler - Seminars in reproductive endocrinology, 1997 - thieme-connect.com
The polycystic ovary syndrome (PCOS) is a prevalent disorder affecting approximately 6% of
women of reproductive age, and is characterized by anovulation and hyperandrogenism. It …

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

G Conway, D Dewailly… - European journal of …, 2014 - academic.oup.com
Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with
androgen excess in women, which justifies the growing interest of endocrinologists. Great …